Combining microbeam radiotherapy with targeted radiosensitizers could treat tumours while sparing normal brain tissues
Read article: Microbeams plus radiosensitizers could optimize brain cancer treatment
ChartCheck, a treatment evaluation solution from Radformation, helps physicists who are responsible for patient safety to speed up their weekly checks and make them more consistent
Read article: Automated checks build confidence in treatment verification
Researchers present the first dosimetric evaluation comparing VMAT and IMRT on the MR-linac
Read article: Speeding up MR-guided radiotherapy with VMAT
A combination of ultrahigh-dose rate electron and conventional photon radiotherapy could enable FLASH treatments of deep-seated tumours
Read article: Hybrid irradiation could facilitate clinical translation of FLASH radiotherapy
Daily MR imaging could enable treatment adaptation to glioblastoma growth or shrinkage during radiotherapy
Read article: MRI-linac keeps track of brain tumour changes during radiotherapy
Cancer care provider GenesisCare is using LAP’s RadCalc platform to perform software-based quality assurance of all its radiotherapy treatment plans
Read article: RadCalc QA: ensuring safe and efficient radiotherapy throughout Australia
Irradiating tumours containing gold nanoparticles should enhance radiotherapy effectiveness while minimizing potential side effects
Read article: Gold nanoparticles could improve radiotherapy of pancreatic cancer
Researchers demonstrate that targeted alpha-particle treatments can reduce the level of amyloid-beta plaque in mouse brain tissues
Read article: Could targeted alpha therapy help treat Alzheimer’s disease?
Minibeam radiotherapy using a clinical orthovoltage unit successfully treats two patients
Read article: First patients treated using minibeam radiation therapy
Speakers at the recent AAPM Annual Meeting examined the clinical impact and future potential of MR-guided radiotherapy
Read article: MR-guided radiotherapy: where are we now and what does the future hold?
